Tweet
USAID/CAPS DIRECTOR: IMPORT MAKES UP 90% OF MEDICAL MARKET IN ARMENIA
arminfo
2008-08-08 12:43:00
ArmInfo. Import makes up 90% of the medical market in Armenia, CAPS
(Competitive Armenia Private Sector) programme Director heyley
Alexander told ArmInfo when commenting on the results of studies
carried out by CAPS in production, sales and import of pharmaceutical
products in Armenia.
According to him, the studies have shown that not only the consumers
but also the doctors and druggists are often unaware of the Armenian
pharmaceutical enterprises and their products. 'Some consumers,
we have questioned, found it difficult to call even one name of a
drug produced in Armenia or a pharmaceutical enterprise. Moreover,
in most cases, the doctors prescribe import drugs to the patients
even under availability of the Armenian analogues', H. Alexander
said. Talking of the degree of representation of the Armenian
medicines in chemists shops, CAPS director said that though the
Armenian medicines are received by chemists shops, the client are
often recommended foreign-made drugs. H. Alexander also said that the
Armenian pharmaceutists should be more active in the area of marketing.
'Everything is important here: from proper packaging to organization
of sales and advertising', H. Alexander said.
To recall CAPS held studies in the area of pharmaceutics in April-July,
2008, the results of which currently undergo processing for the
next publication.
arminfo
2008-08-08 12:43:00
ArmInfo. Import makes up 90% of the medical market in Armenia, CAPS
(Competitive Armenia Private Sector) programme Director heyley
Alexander told ArmInfo when commenting on the results of studies
carried out by CAPS in production, sales and import of pharmaceutical
products in Armenia.
According to him, the studies have shown that not only the consumers
but also the doctors and druggists are often unaware of the Armenian
pharmaceutical enterprises and their products. 'Some consumers,
we have questioned, found it difficult to call even one name of a
drug produced in Armenia or a pharmaceutical enterprise. Moreover,
in most cases, the doctors prescribe import drugs to the patients
even under availability of the Armenian analogues', H. Alexander
said. Talking of the degree of representation of the Armenian
medicines in chemists shops, CAPS director said that though the
Armenian medicines are received by chemists shops, the client are
often recommended foreign-made drugs. H. Alexander also said that the
Armenian pharmaceutists should be more active in the area of marketing.
'Everything is important here: from proper packaging to organization
of sales and advertising', H. Alexander said.
To recall CAPS held studies in the area of pharmaceutics in April-July,
2008, the results of which currently undergo processing for the
next publication.